Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S20, 2018. DOI: 10.25251/skin.2.supp.20. Disponível em: https://skin.dermsquared.com/skin/article/view/290. Acesso em: 19 apr. 2025.